Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
0.6604
+0.0029 (0.44%)
At close: Jan 2, 2026, 4:00 PM EST
0.6508
-0.0096 (-1.45%)
After-hours: Jan 2, 2026, 7:48 PM EST
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $7 million as of January 2, 2026. Its market cap has decreased by -45.82% in one year.
Market Cap
7.00M
Enterprise Value
-3.56M
1-Year Change
-45.82%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $7.00M, an increase of 40.84%. That is a compound annual growth rate of 2.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 7.00M | 0.07% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |